Hosted on MSN
Prostate cancer patients could avoid overtreatment if NICE updated its guidelines, charity says
Up to 5,000 men a year could avoid potentially harmful treatment for prostate cancer if ‘outdated’ guidelines reflected the latest evidence, a charity has said. Closely monitoring the disease with ...
The National Institute for Health and Care Excellence (NICE) has updated its guidance on the use of cladribine (Mavenclad, Merck) for patients with rapidly evolving severe relapsing-remitting multiple ...
The institute backed the treatment after seeing that biliary tract cancer patients on Ziihera lived for an average 18 months, much longer than those on standard chemo can expect.
UPDATED fertility guidance has been issued by the National Institute for Health and Care Excellence, UK, for patients with endometriosis who are struggling to conceive.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results